We are live on ! Find out more
INBX

Inhibrx, Inc. Common Stock
INBX

Delisted

INBX was delisted on the 29th of May, 2024.

Back to rankings

2 hedge funds and large institutions have $1.16M invested in Inhibrx, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 123 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% less funds holding

Funds holding: 126 → 2 (-124)

100% less capital invested

Capital invested by funds: $1.34B → $1.16M (-$1.34B)

100% less funds holding in top 10

Funds holding in top 10: 4 → 0 (-4)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 123

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-124
Holders Change %
-98.41%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
123
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Viking Global Investors
Viking Global Investors
Connecticut
-$250M
2
PA
Perceptive Advisors
New York
-$149M
3
BlackRock
BlackRock
New York
-$96.2M
4
RCM
RA Capital Management
Massachusetts
-$91.9M
5
State Street
State Street
Massachusetts
-$84.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Manulife (Manufacturers Life Insurance)
76
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$513K -14,673 Closed
Skandinaviska Enskilda Banken (SEB)
77
Skandinaviska Enskilda Banken (SEB)
Sweden
– -$506K -14,499 Closed
Wells Fargo
78
Wells Fargo
California
– -$506K -14,486 Closed
RCI
79
RS Crum Inc
California
– -$494K -14,119 Closed
New York State Common Retirement Fund
80
New York State Common Retirement Fund
New York
– -$485K -13,882 Closed
Creative Planning
81
Creative Planning
Kansas
– -$471K -13,466 Closed
Invesco
82
Invesco
Georgia
– -$435K -12,449 Closed
Janus Henderson Group
83
Janus Henderson Group
United Kingdom
– -$397K -11,370 Closed
VOYA Investment Management
84
VOYA Investment Management
Georgia
– -$397K -11,346 Closed
ET
85
Entropy Technologies
New York
– -$384K -10,982 Closed
Principal Financial Group
86
Principal Financial Group
Iowa
– -$357K -10,218 Closed
FLC
87
Fifth Lane Capital
Texas
– -$357K -10,200 Closed
PL
88
Parkwood LLC
Ohio
– -$339K -9,683 Closed
EFM
89
E Fund Management
China
– -$334K -9,544 Closed
LP
90
LMR Partners
United Kingdom
– -$331K -9,458 Closed
CUAMC
91
China Universal Asset Management Company
China
– -$318K -9,106 Closed
EAM
92
Erste Asset Management
Austria
– -$306K -8,700 Closed
SRL
93
Scientech Research LLC
New Jersey
– -$288K -8,240 Closed
ETC
94
Exchange Traded Concepts
Oklahoma
– -$285K -8,143 Closed
GH
95
GAM Holding
Switzerland
– -$280K -8,000 Closed
HWA
96
HCR Wealth Advisors
California
– -$220K -6,300 Closed
ASRS
97
Arizona State Retirement System
Arizona
– -$204K -5,848 Closed
CL
98
CSS LLC
Illinois
– -$171K -4,900 Closed
Zurich Cantonal Bank
99
Zurich Cantonal Bank
Switzerland
– -$166K -4,755 Closed
AIP
100
Ameritas Investment Partners
Nebraska
– -$119K -3,412 Closed
1 2 3
4
5

INBX Hedge Fund Activity: Q2 2024 in Review

2 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Inhibrx, Inc. Common Stock (INBX) for Q2 2024, worth a combined $1.16M — down 100% from $1.34B a quarter earlier.

Sellers outnumbered buyers: 123 funds closed out of INBX and 0 opened new positions — a net loss of 123 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Viking Global Investors, exiting entirely with an estimated $250M sold.

  • 2 institutional investors held Inhibrx, Inc. Common Stock (INBX) as of Q2 2024, down from 126 in Q1 2024.
  • Funds reported $1.16M of Inhibrx, Inc. Common Stock stock for Q2 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Inhibrx, Inc. Common Stock positions in Q2 2024 and 123 closed out, a net change of -123 holders.
  • The largest Inhibrx, Inc. Common Stock seller in Q2 2024 was Viking Global Investors, an estimated $250M sold.

Based on aggregated 13F filings for Q2 2024.